The invention relates to pharmaceutical compositions and dosage forms comprising full-length recombinant human parathyroid hormone (rhPTH(1-84)). The invention further relates to new and/or improved PTH compositions having improved in-use stability that are resistant to protein degradation in response to physical and chemical stresses.本發明係關於包含全長重組人類副甲狀腺素(rhPTH(1-84))之醫藥組合物及劑型。本發明進一步關於新穎及/或經改良之PTH組合物,其具有經改良之使用中穩定性,該PTH組合物因應物理及化學應力對蛋白質降解具有抗性。